The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus.
Lloyd MaiArundip AsaduzzamanBabak NoamaniPaul R FortinDafna D GladmanZahi ToumaMurray B UrowitzJoan E WitherPublished in: Arthritis research & therapy (2021)
Measurement of the type I IFN signature is a useful tool for predicting the subsequent disease activity course.